Delivery Order SPE2DB20D3103-SPE2DB25FN3L9
Award Date
4/7/25
Potential Completion Date
4/28/25
Potential Value
$5.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,399.71 firm-fixed-price delivery order is for the supply of the medication ZEPOSIA 0.92 MG CAPSULE 30S. The contract has an ultimate completion date of December 3, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,862.79, is for the delivery of ZEPOSIA 0.92 MG CAPSULE 30S, a pharmaceutical product. This is a firm fixed-price delivery order contract with a completion date of March 7, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,862.79 firm fixed-price delivery order is for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of March 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,399.71 fixed-price delivery order is for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a prescription medication, with a completion date of November 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,725.64 firm fixed-price delivery order contract is for the supply of ZEPOSIA 0.92MG CAP 30S, a medical product, with a completion date of April 4, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,620.93, is for the delivery of ZEPOSIA 0.92 MG CAPSULE 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 23, 2025. This contract award is not associated with a set-aside designation. AmerisourceBergen holds a larger...
This is a firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has a ceiling value of $13,862.79 and an ultimate completion date of June 13, 2025. The contract provides for the delivery of the pharmaceutical product ZEPOSIA 0.92 MG CAPSULE 30S. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,241.86 firm fixed-price delivery order is for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a specialty medication, to support military healthcare programs. The contract has an ultimate completion date of February 11, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,862.79, is a Firm Fixed Price Delivery Order for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a pharmaceutical product. The award has an ultimate completion date of March 18, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a $4,620.93 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the provision of ZEPOSIA 0.92 MG CAPSULE 30S, a pharmaceutical product. The contract has a firm-fixed price pricing type and a completion date of December 16, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...